Literature DB >> 16858077

Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps.

Caroline Schirpenbach1, Lysann Seiler, Christiane Maser-Gluth, Felix Beuschlein, Martin Reincke, Martin Bidlingmaier.   

Abstract

BACKGROUND: Measurements of aldosterone have become more common since the recognition that primary aldosteronism is a more frequent cause of hypertension than previously believed. Our aim was to compare concentrations reported by 4 assays for samples obtained after saline infusion during dynamic testing.
METHODS: We tested 104 participants (27 with primary aldosteronism, 30 with essential hypertension, and 47 healthy controls) with the intravenous saline infusion test (2.0 L isotonic saline over 4 h), with repetitive sampling. In all blood samples, aldosterone concentration was measured by an in-house RIA after extraction and chromatography, by 2 commercially available RIAs without extraction (Aldosterone Maia, Adaltis; Active Aldosterone, Diagnostics Systems Laboratories) and by an automated CLIA (Advantage, Nichols Institute Diagnostics).
RESULTS: Correlation coefficients for results of pairs of assays ranged from 0.74 to 0.98. Agreement between commercial assays and in-house RIA was best at the low to intermediate concentrations after saline infusion. Mean (SD) Adaltis and DSL RIA results were 2- to 3-times higher [healthy participants: 78 (25) ng/L and 56 (18) ng/L, respectively] than those obtained by Nichols CLIA [17 (8) ng/L] and in-house RIA [23 (18) ng/L]. Aldosterone concentrations measured by the Nichols CLIA were below the limit of detection (limit of the blank) in 27 of 47 healthy participants.
CONCLUSIONS: Aldosterone concentrations reported by the Adaltis and DSL nonextraction RIAs were consistently higher than those produced by the Nichols CLIA and the in-house RIA. The convenient Nichols CLIA showed better agreement with the in-house RIA, but the concentrations in healthy participants were frequently undetectable by this method. Uncritical application of cutoff values from the literature must be avoided.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16858077     DOI: 10.1373/clinchem.2006.068502

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  26 in total

1.  Laboratory investigation of primary aldosteronism.

Authors:  Michael Stowasser; Paul J Taylor; Eduardo Pimenta; Ashraf H Al-Asaly Ahmed; Richard D Gordon
Journal:  Clin Biochem Rev       Date:  2010-05

Review 2.  Primary aldosteronism: A contrarian view.

Authors:  Norman M Kaplan
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 3.  Principles and clinical applications of liquid chromatography - tandem mass spectrometry for the determination of adrenal and gonadal steroid hormones.

Authors:  A E Kulle; M Welzel; P-M Holterhus; F G Riepe
Journal:  J Endocrinol Invest       Date:  2011-07-05       Impact factor: 4.256

Review 4.  The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

Authors:  Phillip J Monaghan; Brian G Keevil; Peter J Trainer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

5.  Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up.

Authors:  F Pizzolo; G Salvagno; B Caruso; C Cocco; F Zorzi; C Zaltron; A Castagna; L Bertolone; F Morandini; G Lippi; O Olivieri
Journal:  J Hum Hypertens       Date:  2017-08-24       Impact factor: 3.012

6.  Adrenal venous sampling: the learning curve of a single interventionalist with 282 consecutive procedures.

Authors:  Hugo Jakobsson; Katerina Farmaki; Augustinas Sakinis; Olof Ehn; Gudmundur Johannsson; Oskar Ragnarsson
Journal:  Diagn Interv Radiol       Date:  2018 Mar-Apr       Impact factor: 2.630

7.  Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.

Authors:  Ryo Morimoto; Yoshikiyo Ono; Yuta Tezuka; Masataka Kudo; Sachiko Yamamoto; Toshiaki Arai; Celso E Gomez-Sanchez; Hironobu Sasano; Sadayoshi Ito; Fumitoshi Satoh
Journal:  Hypertension       Date:  2017-06-26       Impact factor: 10.190

8.  Aldosterone increases cardiac vagal tone via G protein-coupled oestrogen receptor activation.

Authors:  G Cristina Brailoiu; Khalid Benamar; Jeffrey B Arterburn; Erhe Gao; Joseph E Rabinowitz; Walter J Koch; Eugen Brailoiu
Journal:  J Physiol       Date:  2013-07-22       Impact factor: 5.182

9.  Plasma sodium stiffens vascular endothelium and reduces nitric oxide release.

Authors:  Hans Oberleithner; Christoph Riethmüller; Hermann Schillers; Graham A MacGregor; Hugh E de Wardener; Martin Hausberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

10.  Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients.

Authors:  Miroslav Solar; Eva Malirova; Marek Ballon; Radek Pelouch; Jiri Ceral
Journal:  Eur J Endocrinol       Date:  2012-01-17       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.